ZYRTALK
LIVE

Serial Number

97835527

Owner

UCB BIOPHARMA SRL

Attorney

Kumiko Ide

First Use Date

Jun 30, 2023

Filing Date

Mar 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ZYRTALK Trademark

Serial Number: 97835527 • Registration: 8043134

ZYRTALK is a trademark filed by UCB BIOPHARMA SRL on March 13, 2023. The trademark is classified under Class 41 (Education & Entertainment), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

UCB BIOPHARMA SRL (112 trademarks)

Brussels B-1070 , BE

Entity Type: 99

Trademark Details

Filing Date

March 13, 2023

Registration Date

November 25, 2025

First Use Anywhere

June 30, 2023

First Use in Commerce

June 30, 2023

Published for Opposition

September 17, 2024

Goods & Services

providing information in the field of antihistamine and decongestant preparations, and the treatment and diagnosis of allergies

educational and entertainment services, namely, a series of online non-downloadable videos in the field of antihistamine and decongestant preparations, and the treatment and diagnosis of allergies accessible via computer networks, web-based applications, and mobile phone applications

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 25, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 25, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 3, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 3, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 6, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 6, 2025 AITU
USE AMENDMENT FILED
May 7, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
May 7, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 12, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 17, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 17, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 28, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 9, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 8, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 8, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 8, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 8, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 20, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 20, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 20, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 21, 2023 GNRN
NON-FINAL ACTION E-MAILED
Dec 21, 2023 GNRT
NON-FINAL ACTION WRITTEN
Dec 21, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 19, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 19, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 2, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 2, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 2, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 1, 2023 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jul 21, 2023 AMPX
ASSIGNED TO LIE
Jul 21, 2023 ALIE
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 1, 2023 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Mar 16, 2023 PARI
NEW APPLICATION ENTERED
Mar 16, 2023 NWAP